Nano-silver / kaolin composite material, preparation method thereof and application of nano-silver / kaolin composite material in preparation of hemostatic and antibacterial tablets

By combining nano-silver/kaolin composite material with gypsum powder to prepare hemostatic and antibacterial tablets, the problems of unsatisfactory hemostatic effects and lack of antibacterial properties of existing hemostatic materials are solved, achieving the effects of efficient hemostasis, antibacterial properties and enhanced material strength.

CN118903523APending Publication Date: 2024-11-08SHANGHAI CHEST HOSPITAL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410957320.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-17
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Existing hemostatic materials are not ideal for distal radial artery pressure hemostasis and have no antibacterial effect. Furthermore, traditional hemostatic agents are expensive and unstable, the hemostatic mechanism of kaolin has not been fully utilized, and the antibacterial properties of nano-silver have not been applied in hemostatic materials.

Method used

A hemostatic and antibacterial tablet was prepared by using a nano-silver/kaolin composite material, which was prepared by mixing silver nitrate and kaolin and reducing it with ascorbic acid. The tablet was then combined with gypsum powder to form a hemostatic and antibacterial tablet, utilizing the antibacterial properties of nano-silver and the hemostatic mechanism of kaolin.

Benefits of technology

The prepared hemostatic and antibacterial tablets have good hemostatic and antibacterial effects, and are non-toxic to fibroblasts, promoting their proliferation, reducing the brittleness of gypsum, and improving compressive strength.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118903523A_ABST
    Figure CN118903523A_ABST
Patent Text Reader

Abstract

The invention discloses a nano-silver / kaolin composite material, a preparation method thereof and application of the nano-silver / kaolin composite material in preparation of hemostatic and antibacterial tablets. The preparation method of the nano-silver / kaolin composite material comprises the following steps that S11, silver nitrate is taken and added into water to be dissolved, and then a silver nitrate solution is obtained; s12, pouring the silver nitrate solution into kaolin, and uniformly stirring to obtain a silver nitrate-kaolin suspension; and S13, adding an ascorbic acid solution into the silver nitrate-kaolin suspension, stirring until the color of the suspension does not change any more, separating precipitates, and washing to obtain the nano-silver / kaolin composite material. Researches show that the hemostatic and antibacterial tablet prepared by mixing the nano-silver / kaolin composite material and gypsum powder has good hemostatic effect, antibacterial effect and compressive strength, is non-toxic to fibroblasts and can promote proliferation of the fibroblasts; therefore, the hemostatic material has important application value in hemostatic and antibacterial aspects of the far-end radial artery.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of hemostatic material preparation, and in particular to a nano silver / kaolin composite material and a preparation method thereof and application in the preparation of hemostatic and antibacterial pressed tablets. Background Art

[0002] The traditional distal radial artery pressurized hemostatic material does not have an ideal hemostatic effect by physical compression alone, and has no antibacterial effect. The use of hemostatic agents, such as fibrin sealants and poly IV-acetylglucosamine dressings, is subject to certain restrictions due to its high cost and unstable properties. The US National Naval Medical Center has developed a kaolinite derivative with a rapid hemostatic effect, the main component of which is zeolite. Zeolite has a strong physical adsorption effect on polar molecules such as water due to its large specific surface area and strong internal electric field, which can concentrate blood components and increase the relative concentration of local coagulation factors in bleeding, thereby achieving a hemostatic effect. However, zeolite releases a lot of heat in the process of absorbing water, which can easily cause secondary burns to the wound. Some scholars have found that some layered clay minerals, especially kaolinite, have similar hemostatic effects, but different hemostatic mechanisms.

[0003] Kaolin is a 1:1 clay mainly composed of kaolinite and aluminosilicate. Scholars have found that kaolin plays an active role in accelerating the natural coagulation of human blood. Its hemostatic mechanism mainly includes two aspects: one is the physical hemostatic process, by absorbing water molecules, thrombin causes platelets to concentrate in the blood, thereby initiating the natural coagulation of the blood; the second is to activate coagulation factor XII (FXII), start the coagulation cascade reaction, and form water-insoluble blood fibers. In addition, kaolin does not contain proteins of animal or human origin that may cause allergic reactions. Therefore, it has obvious advantages as a local hemostatic agent. When kaolin powder is used to stop bleeding at the wound site, kaolin can quickly absorb water molecules in the blood, instantly accelerate the activation of FXII to FXIIa, stimulate the intrinsic coagulation pathway, and generate thrombin (such as FXIIa) that causes the formation of coagulation factors and platelet activation and aggregation. Figure 1 shown).

[0004] Research in recent years has found that silver ions are one of the metal ions with the strongest bactericidal and antibacterial activity, and nanosilver can slowly release silver ions through its surface, so it has excellent antibacterial properties and has become the antibacterial material with the most development potential.

[0005] However, there is no research report on the preparation of hemostatic and antibacterial compressed tablets using kaolin as raw material in the prior art; in particular, the hemostatic and antibacterial effect, strength and biological toxicity of the prepared hemostatic and antibacterial compressed tablets are technical problems that need to be further solved. Summary of the invention

[0006] In order to overcome at least one of the technical problems existing in the prior art, the present invention provides a nano silver / kaolin composite material and a preparation method thereof and an application thereof in preparing hemostatic and antibacterial pressed tablets.

[0007] The above technical problems to be solved by the present invention are achieved through the following technical solutions:

[0008] The present invention provides a method for preparing a nano silver / kaolin composite material, which comprises the following steps:

[0009] S11. Take silver nitrate and add it to water to dissolve it to obtain a silver nitrate solution;

[0010] S12. Pour the silver nitrate solution into the kaolin and stir to obtain a silver nitrate-kaolin suspension;

[0011] S13. Add ascorbic acid solution to the silver nitrate-kaolin suspension, stir until the suspension does not change color, separate the precipitate, wash and obtain a nano-silver / kaolin composite material.

[0012] The present invention provides a novel method for preparing a nano silver / kaolin composite material; studies have shown that the nano silver / kaolin composite material prepared by the method of the present invention not only has a good hemostatic effect, but also has a good antibacterial effect.

[0013] Preferably, the mass ratio of silver nitrate to kaolin is 1:1-3.

[0014] Preferably, the usage ratio of silver nitrate to water is 1 g:500-1000 mL.

[0015] Most preferably, the ratio of silver nitrate to water is 1 g:600 mL.

[0016] Preferably, the ascorbic acid solution refers to an ascorbic acid aqueous solution with a mass fraction of 5 to 15%.

[0017] Most preferably, the ascorbic acid solution refers to an ascorbic acid aqueous solution with a mass fraction of 10%.

[0018] Preferably, the volume ratio of the silver nitrate-kaolin suspension to the ascorbic acid solution is 10:2-5;

[0019] Most preferably, the volume ratio of the silver nitrate-kaolin suspension to the ascorbic acid solution is 10:3.

[0020] The invention also provides a nano silver / kaolin composite material prepared by the preparation method.

[0021] The present invention also provides an application of the nano silver / kaolin composite material in preparing hemostatic and antibacterial pressed tablets.

[0022] Preferably, the hemostatic and antibacterial compressed tablet is prepared by the following method:

[0023] S21. Mixing water and gypsum powder to form gypsum slurry;

[0024] S22. Add the nano silver / kaolin composite material prepared by the above preparation method into the gypsum slurry, stir evenly and pour into a mold, and obtain the hemostatic and antibacterial pressed tablet after solidification.

[0025] Preferably, the mass ratio of water to gypsum powder is 1:2-4.

[0026] Most preferably, the mass ratio of water to gypsum powder is 1:3.

[0027] Preferably, the mass ratio of gypsum powder to the nano silver / kaolin composite material is 1-3:1-3.

[0028] Most preferably, the mass ratio of gypsum powder to the nano-silver / kaolin composite material is 1:1.

[0029] Beneficial effects:

[0030] (1) The present invention provides a novel method for preparing a nano-silver / kaolin composite material; studies have shown that the nano-silver / kaolin composite material prepared by the method of the present invention not only has a good hemostatic effect, but also has a good antibacterial effect; the hemostatic and antibacterial compressed tablet prepared by mixing the nano-silver / kaolin composite material of the present invention with gypsum powder can make the hemostatic and antibacterial compressed tablet have good hemostatic and antibacterial effects;

[0031] (2) In addition, the hemostatic and antibacterial pressed tablets prepared by mixing the nano-silver / kaolin composite material of the present invention with gypsum powder can also make the nano-silver / kaolin composite material have higher compressive strength, which can reduce the brittleness of gypsum compared with gypsum, and has important application value in hemostatic applications.

[0032] (3) In particular, the hemostatic and antibacterial compressed tablets prepared by mixing the nano-silver / kaolin composite material of the present invention with gypsum powder have no toxic effect on fibroblasts and can promote the proliferation of fibroblasts.

[0033] In summary, the hemostatic and antibacterial compressed tablet of the present invention has good hemostatic effect, antibacterial effect, and compressive strength, and is non-toxic to fibroblasts and can promote the proliferation of fibroblasts; therefore, it has important application value in distal radial artery hemostasis and antibacterial properties. BRIEF DESCRIPTION OF THE DRAWINGS

[0034] Figure 1 Schematic diagram of kaolin hemostasis.

[0035] Figure 2 Macroscopic images of different nano-silver / kaolin composite materials: (a) kaolin; (b) macroscopic image of the nano-silver / kaolin composite material of Example 1; (c) macroscopic image of the nano-silver / kaolin composite material of Example 2; (d) macroscopic image of the nano-silver / kaolin composite material of Example 3.

[0036] Figure 3 SEM images of macroscopic images of different nanosilver / kaolin composite materials: (a) kaolin; (b) SEM image of the nanosilver / kaolin composite material of Example 1; (c) SEM image of the nanosilver / kaolin composite material of Example 2; (d) SEM image of the nanosilver / kaolin composite material of Example 3.

[0037] Figure 4 EDS images of macroscopic images of different nano-silver / kaolin composite materials: (a) kaolin; (b) EDS image of the nano-silver / kaolin composite material of Example 1; (c) EDS image of the nano-silver / kaolin composite material of Example 2; (d) EDS image of the nano-silver / kaolin composite material of Example 3.

[0038] Figure 5 This is a macroscopic image of Ag / GS prepared in Example 4.

[0039] Figure 6 This is the SEM image of Ag / GS prepared in Example 4.

[0040] Figure 7 This is the EDS graph of Ag / GS prepared in Example 4.

[0041] Figure 8 Macroscopic images and compression curves of gypsum and Ag / GS prepared in Example 4 before and after compression

[0042] Fig. 9 Changes in OD values ​​at 450nm wavelength in CCK-8 test of fibroblasts treated with different samples for 24h, 48h, and 72h.

[0043] Fig.10 Red blood cell adsorption diagram of gypsum and Ag / GS prepared in Example 4: (a) gypsum surface; (b) Ag / GS.

[0044] Fig.11 Antibacterial plating effect diagram: (a) normal culture; (b) adding gypsum extract; (c) adding Ag / GS extract. DETAILED DESCRIPTION

[0045] The present invention is further explained below in conjunction with specific examples, but the examples do not limit the present invention in any form.

[0046] Example 1 Preparation of Nanosilver / Kaolin Composite Material

[0047] S11. Take silver nitrate and add it to water to dissolve it to obtain a silver nitrate solution;

[0048] S12. Pour the silver nitrate solution into the kaolin and stir to obtain a silver nitrate-kaolin suspension;

[0049] S13. Add ascorbic acid solution to the silver nitrate-kaolin suspension, stir until the suspension does not change color, separate the precipitate, wash and obtain a nano-silver / kaolin composite material.

[0050] Among them, the mass ratio of silver nitrate to kaolin is 1:3; the dosage ratio of silver nitrate to water is 1g:600mL; the ascorbic acid solution refers to an ascorbic acid aqueous solution with a mass fraction of 10%; the volume ratio of the silver nitrate-kaolin suspension to the ascorbic acid solution is 10:3.

[0051] Example 2 Preparation of Nanosilver / Kaolin Composite Material

[0052] The difference between Example 2 and Example 1 is that the mass ratio of silver nitrate to kaolin is different, and the rest is the same as Example 1.

[0053] In Example 2, the mass ratio of silver nitrate to kaolin is 1:2.

[0054] Example 3 Preparation of Nanosilver / Kaolin Composite Material

[0055] The difference between Example 3 and Example 1 is that the mass ratio of silver nitrate to kaolin is different, and the rest is the same as Example 1.

[0056] In Example 2, the mass ratio of silver nitrate to kaolin is 1:1.

[0057] The experimental results of the nano silver / kaolin composite materials prepared in Examples 1 to 3 are as follows:

[0058] Figure 2 The macroscopic images of nano-silver / kaolinite composites prepared with different silver nitrate / kaolinite mass ratios. Figure 2 As can be seen in (a), the kaolin without silver nitrate is a white powder. In (b), (c), and (d), after adding silver nitrate, under the reduction of ascorbic acid, the silver nitrate will be reduced on the surface of kaolin to generate nanosilver, making the obtained composite powder appear gray-black. It can also be seen from the figure that the color of the composites prepared by different silver nitrate / kaolinite mass ratios is basically the same, so different mass ratios have no obvious effect on the macroscopic appearance of the composite.

[0059] Figure 3The scanning electron microscope images of different samples show that as the mass ratio of silver nitrate to kaolinite increases, the composite is more likely to aggregate. This is because as the amount of silver nitrate increases, the amount of nanosilver generated by reduction also gradually increases, the surface energy per unit area increases, and it is in an unstable state, so it is easy to coagulate and aggregate.

[0060] In order to understand the change of silver content in the composites prepared with different silver nitrate / kaolinite mass ratios, EDS analysis was carried out, such as Figure 4 As shown in Figure (a), kaolin is mainly composed of O, Al, and Si elements. As shown in Figures (b), (c), (d) and Table 1, the composite contains not only kaolin but also silver elements, and as the proportion of silver nitrate increases, the content of silver elements gradually increases.

[0061] Table 1 Element percentage of nanosilver / kaolinite composites with different silver nitrate / kaolinite mass ratios

[0062]

[0063] The above test shows that when the mass ratio of silver nitrate to kaolinite is 1:1, the content of silver in the nano-silver / kaolinite composite is the highest. In order to achieve the best bactericidal effect, the nano-silver / kaolinite composite powder prepared in this ratio is selected as the hemostatic and antibacterial additive for ceramic tablets.

[0064] Example 4 Preparation of hemostatic and antibacterial compressed tablets

[0065] S21. Mixing water and gypsum powder to form gypsum slurry;

[0066] S22. The nanosilver / kaolin composite material prepared according to the method described in Example 3 was added to the gypsum slurry, stirred evenly and poured into a mold, and solidified to obtain the hemostatic and antibacterial tablet;

[0067] The mass ratio of water to gypsum powder is 1:3; the mass ratio of gypsum powder to nano-silver / kaolin composite material is 1:1.

[0068] Figure 5 This is a macroscopic image of the hemostatic antibacterial pressed tablet (abbreviated as Ag / GS) ​​prepared in Example 4. From the figure, it can be seen that the ceramic tablet is gray, indicating that the composite powder is evenly dispersed in the ceramic tablet.

[0069] Figure 6 This is the SEM image of Ag / GS. It can be seen from the figure that there are many pores on the surface of the sample. This porous structure may further improve the hemostatic performance of the material.

[0070] In order to verify whether the Ag / GS surface contains nanosilver / kaolinite composite materials, EDS analysis was performed on the material. Figure 7 As can be seen from Table 2, Ag / GS contains Al, Si, and Ag elements, indicating that the sample surface contains composite materials, and the Ga element in the spectrum comes from gypsum (calcium sulfate).

[0071] Table 2 Ag / GS element percentage

[0072]

[0073] Example 4 Compressive strength test of the prepared hemostatic antibacterial tablet (abbreviated as Ag / GS): The compression test standard of this compression test is in accordance with GB4740-1999-T Ceramic Material Compressive Strength Test Method. The sample is a gypsum and Ag / GS sample with a diameter of 20mm and a height of 20mm. Before the test, the sample is placed in an oven at 110℃ and dried for 2h. The test results are as follows Figure 8 As shown, it can be seen from the figure that the compressive strength of the pure gypsum sample without adding the nano silver / kaolinite composite material is 25MPa, while the compressive strength of the Ag / GS material mixed with the nano silver / kaolinite composite material and the gypsum slurry is 23MPa, and the compressive strength is basically consistent with that of gypsum, indicating that the addition of the nano silver / kaolinite composite material of the present invention has no significant effect on the strength of gypsum. It can also be seen from the figure that the deformation amplitude of the Ag / GS sample shows a slower trend than that of the gypsum sample, indicating that the addition of the nano silver / kaolinite composite material of the present invention can reduce the brittleness of gypsum. In summary, Ag / GS has a higher compressive strength and can meet the use of high-strength hemostat tablets.

[0074] Example 4 Biocompatibility test of the hemostatic antibacterial compressed tablet (abbreviated as Ag / GS): In order to verify whether the Ag / GS material is toxic to cells, the biocompatibility test of gypsum and Ag / GS materials was carried out. The test used the CCK-8 (Cell Counting Kit-8) method to conduct toxicity experimental analysis on the composite coating material, and the experimental group was divided into 3 groups, namely the Ctrl group, the S group, and the Ag / GS group. Among them, the Ctrl group had no material added and was a blank control group; the S group was a solid gypsum material; the experimental material of the Ag / GS group was nanosilver / kaolinite-gypsum material.

[0075] The samples were placed in a 24-well plate, with 1.25 cm 2 / mL of immersion ratio in αMEM medium containing 10% FBS, and placed in a cell culture incubator at 37°C with 5% CO2. After 72 hours, the extract was filtered with a 0.22μm filter and diluted 8 times for cell experiments. After the extract was prepared, 100μL of 3×10 4 / mL of fibroblast suspension was inoculated in a 96-well plate, 5 wells were inoculated in each group, and cultured in a cell culture incubator at 37°C and 5% CO2 volume fraction for 24 hours. After the cells adhered to the wall and grew, the original culture medium was discarded, and 100μL of gypsum and nanosilver / kaolinite-gypsum sample extract was added to each group, and the control group was α-MEM culture medium containing 10% FBS, and culture continued. The 96-well plate was taken out at 24h, 48h and 72h, the supernatant was aspirated, and 100μL of α-MEM culture medium containing 10% CCK8 was added to each well and cultured for 4 hours. The OD value of each group was measured with an automatic microplate reader at a wavelength of 450nm. The results are shown as follows: Fig. 9 shown.

[0076] from Fig. 9 It can be seen that the OD values ​​of gypsum-treated fibroblasts measured at 24h, 48h, and 72h were not significantly different from those of normal fibroblasts; while the OD values ​​of the Ag / GS group measured at 24h, 48h, and 72h were significantly higher than those of normal cells, indicating that Ag / GS had no toxic effect on fibroblasts in the first 72h and may promote the proliferation of fibroblasts.

[0077] Example 4 Blood cell adsorption test of the prepared hemostatic antibacterial compressed tablet (abbreviated as Ag / GS): In order to verify whether the composite material has a hemostatic effect, gypsum and Ag / GS were subjected to blood cell adsorption tests. The materials were immersed in anticoagulated rabbit blood respectively, and after incubation at 37°C for 30 minutes, the samples were taken out and washed three times with PBS to remove the free blood cells and platelets that were not adsorbed. Then, they were fixed with 3% glutaraldehyde for 3 hours, and then the samples were taken out and washed three times with PBS to remove the glutaraldehyde. Subsequently, the samples were dehydrated using ethanol solutions with concentrations of 30%, 50%, 70%, 90%, and 100% (V / V) respectively, and the treatment time was 10 minutes. The dehydrated samples were air-dried at 37°C. Finally, 5nm of gold was uniformly sprayed on the surface of the samples, and the samples were scanned and photographed using a scanning electron microscope at an accelerating voltage of 3kV.

[0078] Fig.10 The SEM images of gypsum and Ag / GS samples adsorbing red blood cells are shown in Figure 2. From the figure, we can see that red blood cells are adsorbed on the surfaces of both samples, and the number of red blood cells adsorbed by the Ag / GS sample is greater, indicating that Ag / GS has a better hemostatic effect.

[0079] Antibacterial test of the hemostatic antibacterial compressed tablet (abbreviated as Ag / GS) ​​prepared in Example 4: To verify the antibacterial properties of the Ag / GS composite material, Staphylococcus aureus (S. aureus) was selected for in vitro antibacterial test. In order to achieve a better plating effect, 5 μl of bacterial solution and 400 μl of 6-fold diluted gypsum and Ag / GS sample extract were selected for antibacterial experiments. The experiment was divided into 3 groups, namely Control group, S group, and Ag / GS group. The control experimental conditions were the same. The growth of the colony was observed after 48 hours of culture, and a digital camera was used to take pictures and record the results. Fig.11 shown.

[0080] from Fig.11 In the control group culture medium with only bacterial solution added, S. aureus grew in sheets and covered the entire culture medium. In the other two experimental groups where the extract of experimental materials and bacterial solution were co-cultured, the number of bacteria decreased, and the number of bacteria on the culture dish of the Ag / GS group decreased significantly, indicating that Ag / GS has a strong bactericidal effect.

Claims

1. A method for preparing a nano silver / kaolin composite material, characterized in that: The following steps are included: S11. Take silver nitrate and add it to water to dissolve it to obtain a silver nitrate solution; S12. Pour the silver nitrate solution into the kaolin and stir to obtain a silver nitrate-kaolin suspension; S13. Add ascorbic acid solution to the silver nitrate-kaolin suspension, stir until the suspension does not change color, separate the precipitate, wash and obtain a nano-silver / kaolin composite material.

2. The preparation method according to claim 1, characterized in that: The mass ratio of silver nitrate to kaolin is 1:1-3.

3. The preparation method according to claim 1, characterized in that: The dosage ratio of silver nitrate to water is 1g:500~1000mL.

4. The preparation method according to claim 3, characterized in that: The dosage ratio of silver nitrate to water is 1g:600mL.

5. The preparation method according to claim 1, characterized in that: The ascorbic acid solution is an ascorbic acid aqueous solution with a mass fraction of 5 to 15%.

6. The preparation method according to claim 5, characterized in that: The ascorbic acid solution is an ascorbic acid aqueous solution with a mass fraction of 10%.

7. The preparation method according to claim 5, characterized in that: The volume ratio of the silver nitrate-kaolin suspension to the ascorbic acid solution is 10:2-5.

8. The nano silver / kaolin composite material prepared by the preparation method according to any one of claims 1 to 7.

9. Use of the nano silver / kaolin composite material according to claim 8 in the preparation of hemostatic and antibacterial compressed tablets.

10. The use according to claim 9, characterized in that: The hemostatic and antibacterial compressed tablet is prepared by the following method: S21. Mixing water and gypsum powder to form gypsum slurry; S22. Add the nano silver / kaolin composite material prepared by the preparation method according to any one of claims 1 to 7 into the gypsum slurry, stir evenly and pour into a mold, and obtain the hemostatic and antibacterial pressed tablet after solidification.